Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
24,650
+50 (0.20%)
At close: Oct 2, 2025
0.20%
Market Cap171.09B
Revenue (ttm)68.76B
Net Income (ttm)11.60B
Shares Out6.97M
EPS (ttm)1,702.00
PE Ratio14.42
Forward PEn/a
Dividend1,000.00 (4.07%)
Ex-Dividend DateDec 27, 2024
Volume4,753
Average Volume10,355
Open24,600
Previous Close24,600
Day's Range24,350 - 24,700
52-Week Range14,500 - 31,450
Beta-0.30
RSI52.51
Earnings DateNov 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.